Cargando…
A comprehensive study on regulatory requirements for development and filing of generic drugs globally
The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be es...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555014/ https://www.ncbi.nlm.nih.gov/pubmed/23373001 http://dx.doi.org/10.4103/2230-973X.104392 |
_version_ | 1782256994989637632 |
---|---|
author | Handoo, Shweta Arora, Vandana Khera, Deepak Nandi, Prafulla Kumar Sahu, Susanta Kumar |
author_facet | Handoo, Shweta Arora, Vandana Khera, Deepak Nandi, Prafulla Kumar Sahu, Susanta Kumar |
author_sort | Handoo, Shweta |
collection | PubMed |
description | The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be established before commencement of developmental work in order to avoid major surprises after submission of the application. The role of the regulatory authorities is to ensure the quality, safety, and efficacy of all medicines in circulation in their country. It not only includes the process of regulating and monitoring the drugs but also the process of manufacturing, distribution, and promotion of it. One of the primary challenges for regulatory authority is to ensure that the pharmaceutical products are developed as per the regulatory requirement of that country. This process involves the assessment of critical parameters during product development. |
format | Online Article Text |
id | pubmed-3555014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35550142013-01-31 A comprehensive study on regulatory requirements for development and filing of generic drugs globally Handoo, Shweta Arora, Vandana Khera, Deepak Nandi, Prafulla Kumar Sahu, Susanta Kumar Int J Pharm Investig Review Article The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be established before commencement of developmental work in order to avoid major surprises after submission of the application. The role of the regulatory authorities is to ensure the quality, safety, and efficacy of all medicines in circulation in their country. It not only includes the process of regulating and monitoring the drugs but also the process of manufacturing, distribution, and promotion of it. One of the primary challenges for regulatory authority is to ensure that the pharmaceutical products are developed as per the regulatory requirement of that country. This process involves the assessment of critical parameters during product development. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3555014/ /pubmed/23373001 http://dx.doi.org/10.4103/2230-973X.104392 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Handoo, Shweta Arora, Vandana Khera, Deepak Nandi, Prafulla Kumar Sahu, Susanta Kumar A comprehensive study on regulatory requirements for development and filing of generic drugs globally |
title | A comprehensive study on regulatory requirements for development and filing of generic drugs globally |
title_full | A comprehensive study on regulatory requirements for development and filing of generic drugs globally |
title_fullStr | A comprehensive study on regulatory requirements for development and filing of generic drugs globally |
title_full_unstemmed | A comprehensive study on regulatory requirements for development and filing of generic drugs globally |
title_short | A comprehensive study on regulatory requirements for development and filing of generic drugs globally |
title_sort | comprehensive study on regulatory requirements for development and filing of generic drugs globally |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555014/ https://www.ncbi.nlm.nih.gov/pubmed/23373001 http://dx.doi.org/10.4103/2230-973X.104392 |
work_keys_str_mv | AT handooshweta acomprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally AT aroravandana acomprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally AT kheradeepak acomprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally AT nandiprafullakumar acomprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally AT sahususantakumar acomprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally AT handooshweta comprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally AT aroravandana comprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally AT kheradeepak comprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally AT nandiprafullakumar comprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally AT sahususantakumar comprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally |